Systemic Anti-Cancer Therapy Regimen Library New Zealand Formulary

Urogenital Regimens

Non-Prostate Regimens

Bladder and Urothelial Regimens

Published Sort regimens by
GU BLA - mitomycin and fluorouracil chemoradiation Id: 265051000210101 Published date: Version: 1.0.0
265051000210101
1.0.0
21/08/2023
GU Bladder Urothelial Adjuvant - ddMVAC [metHOTREXATe, DOXOrubicin, vinBLASTine and cISplatin] dose dense Id: 265311000210102 Published date: Version: 2.0.0
265311000210102
2.0.0
08/05/2026
GU Bladder Urothelial - cISplatin [Q1W] chemoradiation Id: 265451000210109 Published date: Version: 2.0.0
265451000210109
2.0.0
07/05/2026
GU Bladder Urothelial - gemcitabine [low dose] chemoradiation Id: 265331000210109 Published date: Version: 1.0.0
265331000210109
1.0.0
24/08/2023
GU Bladder Urothelial Neoadjuvant - cISplatin and gemcitabine Id: 265061000210103 Published date: Version: 2.0.0
265061000210103
2.0.0
08/05/2026
GU Bladder Urothelial Neoadjuvant - ddMVAC [metHOTREXATe, DOXOrubicin, vinBLASTine and cISplatin] dose dense Id: 265321000210107 Published date: Version: 2.0.0
265321000210107
2.0.0
08/05/2026
GU Upper Tract Urothelial Adjuvant - cARBOplatin and gemcitabine Id: 264991000210108 Published date: Version: 1.0.0
264991000210108
1.0.0
21/08/2023
GU Upper Tract Urothelial Adjuvant - cISplatin and gemcitabine Id: 264981000210106 Published date: Version: 2.0.0
264981000210106
2.0.0
08/05/2026
GU Upper Tract Urothelial Adjuvant - cISplatin [split dose] and gemcitabine Id: 391431000210108 Published date: Version: 2.0.0
391431000210108
2.0.0
08/05/2026
GU URO Advanced - avelumab Q2W [flat dosing] Id: 265441000210106 Published date: Version: 1.0.0
265441000210106
1.0.0
24/08/2023
GU URO Advanced - cARBOplatin and gemcitabine Id: 265001000210102 Published date: Version: 1.0.0
265001000210102
1.0.0
21/08/2023
GU URO Advanced - cISplatin and gemcitabine Id: 391451000210102 Published date: Version: 2.0.0
391451000210102
2.0.0
08/05/2026
GU URO Advanced - cISplatin [split dose] and gemcitabine Id: 391441000210100 Published date: Version: 2.0.0
391441000210100
2.0.0
07/05/2026
GU URO Advanced - cISplatin, gemcitabine and nivolumab Id: 496501000210100 Published date: Version: 2.0.0
496501000210100
2.0.0
08/05/2026
GU URO Advanced - enfortumab vedotin Id: 496761000210106 Published date: Version: 1.0.0
496761000210106
1.0.0
29/01/2025
GU URO Advanced - enfortumab vedotin and pembrolizumab Id: 496711000210109 Published date: Version: 1.0.0
496711000210109
1.0.0
29/01/2025
GU URO Advanced - pembrolizumab Q3W [flat dosing] Id: 265131000210106 Published date: Version: 1.0.0
265131000210106
1.0.0
21/08/2023
GU URO Advanced - pembrolizumab Q6W [flat dosing] Id: 265121000210109 Published date: Version: 1.0.0
265121000210109
1.0.0
21/08/2023
GU URO Metastatic - PACLItaxel [Q1W] Id: 265191000210107 Published date: Version: 1.0.0
265191000210107
1.0.0
21/08/2023
GU URO Metastatic - PACLItaxel Q1W and pembrolizumab Q3W [flat dosing] Id: 265351000210103 Published date: Version: 1.0.0
265351000210103
1.0.0
24/08/2023
GU URO Neoadjuvant/Adjuvant - cISplatin, gemcitabine and durvalumab Id: 496981000210100 Published date: Version: 2.0.0
496981000210100
2.0.0
08/05/2026
GU URO Neoadjuvant/Adjuvant - cISplatin [split dose], gemcitabine and durvalumab Id: 496991000210103 Published date: Version: 1.0.0
496991000210103
1.0.0
09/02/2025

Penile Regimens

Published Sort regimens by
GU Penile Advanced - TIP [PACLItaxel, IFOSFamide and cISplatin] [3-day] Id: 265301000210104 Published date: Version: 2.0.0
265301000210104
2.0.0
24/08/2026
GU Penile Advanced - TIP [PACLItaxel, IFOSFamide and cISplatin] [5-day] Id: 265291000210103 Published date: Version: 3.0.0
265291000210103
3.0.0
24/08/2026
GU Penile Advanced - TPF [DOCEtaxel, cISplatin, fluorouracil] Id: 265281000210100 Published date: Version: 2.0.0
265281000210100
2.0.0
08/05/2026

Renal Regimens

Published Sort regimens by
GU Renal cell Adjuvant - pembrolizumab Q3W [flat dosing] Id: 496461000210100 Published date: Version: 1.0.0
496461000210100
1.0.0
10/12/2024
GU Renal cell Advanced - nivolumab and ipilimumab induction followed by nivolumab maintenance Q2W [flat dosing] Id: 265391000210105 Published date: Version: 1.0.0
Components ▾
Part 1: nivolumab and ipilimumab induction Id: 265371000210106 Published date: Version: 0.0.8
Part 2: nivolumab maintenance Q2W [flat dosing] Id: 265401000210108 Published date: Version: 0.0.4
265391000210105
1.0.0
24/08/2023
GU Renal cell Advanced - nivolumab and ipilimumab induction followed by nivolumab maintenance Q4W [flat dosing] Id: 265361000210100 Published date: Version: 1.0.0
Components ▾
Part 1: nivolumab and ipilimumab induction Id: 265371000210106 Published date: Version: 0.0.8
Part 2: nivolumab maintenance Q4W [flat dosing] Id: 265381000210108 Published date: Version: 0.0.6
265361000210100
1.0.0
24/08/2023
GU Renal cell Advanced - nivolumab Q2W [flat dosing] Id: 265171000210108 Published date: Version: 1.0.0
265171000210108
1.0.0
21/08/2023
GU Renal cell Advanced - nivolumab Q4W [flat dosing] Id: 265161000210102 Published date: Version: 1.0.0
265161000210102
1.0.0
21/08/2023
GU Renal cell Metastatic - aXITinib Id: 264961000210103 Published date: Version: 1.0.0
264961000210103
1.0.0
21/08/2023
GU Renal cell Metastatic - aXITinib and pembrolizumab Q3W [flat dosing] Id: 265111000210104 Published date: Version: 1.0.0
265111000210104
1.0.0
21/08/2023
GU Renal cell Metastatic - aXITinib and pembrolizumab Q6W [flat dosing] Id: 265101000210101 Published date: Version: 1.0.0
265101000210101
1.0.0
21/08/2023
GU Renal cell Metastatic - beVACizumab and erlotinib Id: 265481000210104 Published date: Version: 2.0.0
265481000210104
2.0.0
24/08/2026
GU Renal cell Metastatic - cABOZANtinib Id: 264971000210109 Published date: Version: 1.0.0
264971000210109
1.0.0
21/08/2023
GU Renal cell Metastatic - cABOZANtinib and nivolumab Id: 265421000210100 Published date: Version: 1.0.0
265421000210100
1.0.0
24/08/2023
GU Renal cell Metastatic - everolimus Id: 265091000210108 Published date: Version: 1.0.0
265091000210108
1.0.0
21/08/2023
GU Renal cell Metastatic - leNVAtinib and everolimus Id: 265341000210101 Published date: Version: 2.0.0
265341000210101
2.0.0
03/04/2025
GU Renal cell Metastatic - leNVAtinib and pembrolizumab Q3W [flat dosing] Id: 265181000210105 Published date: Version: 1.0.0
265181000210105
1.0.0
21/08/2023
GU Renal cell Metastatic - pAZOPanib Id: 265151000210100 Published date: Version: 1.0.0
265151000210100
1.0.0
21/08/2023
GU Renal cell Metastatic - pembrolizumab Q3W [flat dosing] Id: 265081000210106 Published date: Version: 1.0.0
265081000210106
1.0.0
21/08/2023
GU Renal cell Metastatic - pembrolizumab Q3W [flat dosing] and ipilimumab Id: 265431000210103 Published date: Version: 1.0.0
265431000210103
1.0.0
24/08/2023
GU Renal cell Metastatic - pembrolizumab Q6W [flat dosing] Id: 265071000210109 Published date: Version: 1.0.0
265071000210109
1.0.0
21/08/2023
GU Renal cell Metastatic - sUNITinib Id: 265141000210103 Published date: Version: 1.0.0
265141000210103
1.0.0
21/08/2023
Discontinued Regimens Sort regimens by
GU Renal cell Metastatic - aXITinib and avelumab [flat dose] Id: 265411000210105 Published date: Version: 1.0.2
265411000210105
1.0.2
20/08/2025

Testicular Regimens

Published Sort regimens by
GU GCT Advanced - EP [etoposide and cISplatin] [3-day] Id: 265471000210101 Published date: Version: 2.0.0
265471000210101
2.0.0
24/08/2026
GU GCT Advanced - EP [etoposide and cISplatin] [5-day] Id: 265021000210105 Published date: Version: 3.0.0
265021000210105
3.0.0
24/08/2026
GU GCT Metastatic - BEP [bleomycin, etoposide and cISplatin] [3-day] Id: 265461000210107 Published date: Version: 2.0.0
265461000210107
2.0.0
24/08/2026
GU GCT Metastatic - BEP [bleomycin, etoposide and cISplatin] [5-day] Id: 265041000210104 Published date: Version: 3.0.0
265041000210104
3.0.0
24/08/2026
GU GCT Metastatic - TI [PACLItaxel and IFOSFamide] [Part ONE of TICE] Id: 393721000210104 Published date: Version: 2.0.0
393721000210104
2.0.0
24/08/2026
GU GCT Metastatic - TIP [PACLItaxel, IFOSFamide and cISplatin] Id: 391421000210106 Published date: Version: 3.0.0
391421000210106
3.0.0
24/08/2026
GU GCT Metastatic - VIP [etoposide, IFOSFamide and cISplatin] Id: 265011000210100 Published date: Version: 3.0.0
265011000210100
3.0.0
24/08/2026
GU GCT Non-seminoma Adjuvant - BEP [bleomycin, etoposide and cISplatin] Id: 265031000210107 Published date: Version: 3.0.0
265031000210107
3.0.0
24/08/2026
GU GCT Seminoma Adjuvant - cARBOplatin [7 AUC] Id: 391461000210104 Published date: Version: 1.0.0
391461000210104
1.0.0
28/04/2024

Prostate Regimens

Published Sort regimens by
GU PROS Castration resistant Metastatic - abiraterone and dexamethasone Id: 52451000210102 Published date: Version: 1.0.0
52451000210102
1.0.0
19/04/2021
GU PROS Castration resistant Metastatic - abiraterone and prEDNISone Id: 52321000210104 Published date: Version: 1.0.0
52321000210104
1.0.0
02/03/2021
GU PROS Castration resistant Metastatic - apalutamide Id: 393381000210104 Published date: Version: 1.0.0
393381000210104
1.0.0
18/08/2024
GU PROS Castration resistant Metastatic - cabazitaxel Q3W and prEDNISone Id: 52511000210102 Published date: Version: 2.0.0
52511000210102
2.0.0
13/08/2023
GU PROS Castration resistant Metastatic - cARBOplatin and DOCEtaxel Id: 52561000210100 Published date: Version: 3.0.0
52561000210100
3.0.0
13/08/2023
GU PROS Castration resistant Metastatic - DOCEtaxel Q2W and prEDNISone Id: 52391000210101 Published date: Version: 1.0.0
52391000210101
1.0.0
03/03/2021
GU PROS Castration resistant Metastatic - DOCEtaxel Q3W and prEDNISone Id: 52381000210103 Published date: Version: 1.0.0
52381000210103
1.0.0
03/03/2021
GU PROS Castration resistant Metastatic - enzalutamide Id: 52531000210109 Published date: Version: 1.0.0
52531000210109
1.0.0
29/06/2021
GU PROS Castration resistant NON-Metastatic - apalutamide Id: 52441000210100 Published date: Version: 1.0.0
52441000210100
1.0.0
19/04/2021
GU PROS Castration resistant NON-Metastatic - darolutamide Id: 393161000210105 Published date: Version: 1.0.0
393161000210105
1.0.0
01/08/2024
GU PROS Castration sensitive Metastatic - abiraterone and prEDNISone Id: 52371000210100 Published date: Version: 1.0.0
52371000210100
1.0.0
03/03/2021
GU PROS Castration sensitive Metastatic - abiraterone and prEDNISone [fed state] Id: 393701000210107 Published date: Version: 1.0.0
393701000210107
1.0.0
18/09/2024
GU PROS Castration sensitive Metastatic - abiraterone micronised [Yonsa] and methylprednisolone Id: 506461000210105 Published date: Version: 1.0.0
506461000210105
1.0.0
28/05/2025
GU PROS Castration sensitive Metastatic - apalutamide Id: 52431000210108 Published date: Version: 1.0.0
52431000210108
1.0.0
19/04/2021
GU PROS Castration sensitive Metastatic - darolutamide Id: 506541000210108 Published date: Version: 1.0.0
506541000210108
1.0.0
05/08/2025
GU PROS Castration sensitive Metastatic - DOCEtaxel, abiraterone and prEDNISone Id: 393631000210106 Published date: Version: 1.0.0
393631000210106
1.0.0
05/09/2024
GU PROS Castration sensitive Metastatic - DOCEtaxel, abiraterone [fed state] and prEDNISone Id: 506401000210106 Published date: Version: 1.0.0
506401000210106
1.0.0
04/05/2025
GU PROS Castration sensitive Metastatic - DOCEtaxel Q3W Id: 52361000210106 Published date: Version: 2.0.0
52361000210106
2.0.0
05/08/2025
GU PROS Castration sensitive Metastatic - DOCEtaxel Q3W and darolutamide Id: 506531000210100 Published date: Version: 1.0.0
506531000210100
1.0.0
05/08/2025
GU PROS Castration sensitive Metastatic - enzalutamide Id: 393101000210106 Published date: Version: 1.0.0
393101000210106
1.0.0
01/08/2024
GU PROS Castration sensitive NON-Metastatic - apalutamide Id: 393371000210101 Published date: Version: 1.0.0
393371000210101
1.0.0
18/08/2024
GU PROS Castration sensitive NON-Metastatic - enzalutamide Id: 506381000210106 Published date: Version: 1.0.0
506381000210106
1.0.0
01/05/2025
GU PROS Locally advanced/Metastatic - degarelix Id: 393091000210104 Published date: Version: 1.0.0
393091000210104
1.0.0
01/08/2024
GU PROS Metastatic - bicalutamide Id: 52421000210106 Published date: Version: 1.0.0
52421000210106
1.0.0
19/04/2021
GU PROS Metastatic - cyproterone Id: 52351000210108 Published date: Version: 1.0.0
52351000210108
1.0.0
03/03/2021
GU PROS Metastatic - denosumab Id: 393081000210101 Published date: Version: 1.0.0
393081000210101
1.0.0
01/08/2024
GU PROS Metastatic - flutamide Id: 52411000210101 Published date: Version: 1.0.0
52411000210101
1.0.0
19/04/2021
GU PROS Metastatic - goserelin Id: 52461000210104 Published date: Version: 1.0.0
52461000210104
1.0.0
19/04/2021
GU PROS Metastatic - olaparib Id: 393061000210109 Published date: Version: 1.0.0
393061000210109
1.0.0
01/08/2024
GU PROS Metastatic - pembrolizumab [flat dose] Id: 52341000210105 Published date: Version: 3.0.0
52341000210105
3.0.0
17/10/2022
GU PROS Metastatic - zoledronic acid Q12W Id: 52541000210101 Published date: Version: 1.0.0
52541000210101
1.0.0
29/06/2021
GU PROS Metastatic - zoledronic acid Q4W Id: 52521000210107 Published date: Version: 1.0.0
52521000210107
1.0.0
29/06/2021
GU PROS Metastatic - zoledronic acid Q6W Id: 59261000210106 Published date: Version: 1.0.0
59261000210106
1.0.0
12/05/2022
GU PROS Small cell prostate cancer - cARBOplatin and etoposide Id: 393071000210103 Published date: Version: 1.0.0
393071000210103
1.0.0
01/08/2024
GU PROS Small cell prostate cancer - cARBOplatin and oral etoposide Id: 393171000210104 Published date: Version: 1.0.0
393171000210104
1.0.0
01/08/2024
Discontinued Regimens Sort regimens by
GU PROS Castration resistant Metastatic - abiraterone and prEDNISone [fed state] Id: 52311000210109 Published date: Version: 1.0.2
52311000210109
1.0.2
20/08/2025
GU PROS Metastatic - peptide receptor radionuclide therapy with lutetium Lu 177 vipivotide tetraxetan Id: 393391000210102 Published date: Version: 1.0.2
393391000210102
1.0.2
20/08/2025